News Focus
News Focus
Followers 6
Posts 55
Boards Moderated 0
Alias Born 08/27/2020

Re: God_Father post# 49009

Saturday, 11/28/2020 3:49:44 AM

Saturday, November 28, 2020 3:49:44 AM

Post# of 202291
Normally antibodies are developed by the immune system after a viral infection so that the antibodies bind the virus and the white blood cells come and eat it (put simply). A vaccine is normally made of a weekend or non-viable viruses that when injected into the body the immune system will recognize and develop antibodies to fight it. Those antibodies will be stored in immune systems' memory cells so when the individual is infected by the harmful virus it can develop the antibodies needed very quickly (somewhat around 3 days give or take).

The vaccines being developed right now are made of mRNA of some of the SARS Covid-19 forms (strains) that allow the body to synthesis the antibodies needed to fight the virus when infected after being vaccinated. Although some vaccines are promising right now, there is a big chance they will not be as effective when given to everyone; simply because we still do not know how long the antibody created due to the mRNA vaccine will last in the body and if the body is capable of producing them after being a while since getting vaccinated.

A high-efficiency vaccine takes not less than 10 years to make, part of that is to study the side effects of them. This is a new era we are in right now.

Monoclonal antibodies have been used for several diseases, and are used extensively in research. They are effective only after getting the disease and they trap the virus to allow white blood cells to destroy them. But testing is necessary to determine the proper antibody shape to trap the spike protein that is on the surface of the Covid-19 virus which plays a huge role in allowing the virus to penetrate the cells so easily.

Also, Vaccines "normally" work only on one strain of the virus. Since all the work for the companies developing the vaccines is kept top secret we do not know the amount of mRNA's in a dose or if it contains mRNAs for more than one strain.

Monoclonal antibodies for different strains of the virus are relatively easier to make and are faster to develop. So for a virus that keeps mutating a vaccine will not be as effective as we all think.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y